相关实验视频
Updated: May 28, 2025

06:37
Immunolabelling Myofiber Degeneration in Muscle Biopsies
Published on: December 5, 2019
8.7K
在炎症性肌肉疾病中的新兴机制和治疗方法
Sven Wischnewski1, Hans-Werner Rausch2, Chiseko Ikenaga3
1Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Trends in pharmacological sciences
|February 12, 2025
概括
异形性炎症性肌肉病 (IIM) 涉及免疫驱动的肌肉损伤. 转录组学和免疫学的最新进展为这些罕见疾病提供了新的治疗点,包括包容体肌炎 (IBM).
科学领域:
- 风湿病学和免疫学
- 神经肌肉疾病 神经肌肉疾病
- 翻译医学是一种翻译医学.
背景情况:
- 异常性炎症性肌肉病变 (IIM) 或肌肉炎是一种罕见的自身免疫性疾病,会导致肌肉损伤,皮肤病变和间歇性肺部疾病 (ILD).
- 尽管取得了进展,但诊断和治疗仍然具有挑战性,目前对于包括体肌炎 (IBM) 没有有效的治疗方法.
研究的目的:
- 审查了解成人IIM病理生理学的最新突破.
- 为IIM和IBM强调新的治疗策略和研究进展,包括转录学和机器学习.
主要方法:
- 审查最近的科学文献,重点关注IIM病理生理学,包括转录学,单细胞分析和免疫学见解.
- 对新兴的治疗点和方法的分析,如仿真抗原受体 (CAR) T 细胞和Janus 激酶 (JAK) 抑制剂.
主要成果:
- 通过转录组学,抗体介导免疫和干扰素 (IFN) 信号传递,澄清了IIM病理生理学.
- 在IBM中确定了独特的免疫和退行性途径,包括2型肌纤维损伤和细胞应激.
- 展示了先进技术的潜力,如单细胞分析和机器学习,以改善诊断和确定治疗点.
结论:
- 最近的科学进展正在改变IIM的研究,为诊断和治疗提供了新的希望.
- 针对IIM的向治疗和个性化治疗策略正在出现,重点是解决IBM的具体挑战.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
99
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
99
Disorders of the Skeletal Muscle
858
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
858
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Centrally Acting Muscle Relaxants: Therapeutic Uses
616
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
616
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
653
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
653

